NIVONASO-21: Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment (clinicaltrials.gov) - Oct 22, 2026 - P2 | N=32 | Recruiting | Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology | Trial completion date: Dec 2025 ➔ Dec 2027 | Trial primary completion date: Dec 2025 ➔ Dec 2027
Trial completion date • Trial primary completion date • Head and Neck Cancer • Nasopharyngeal Carcinoma • Oncology • Solid Tumor
|